Literature DB >> 7699629

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

A Calin1, S Garrett, H Whitelock, L G Kennedy, J O'Hea, P Mallorie, T Jenkinson.   

Abstract

OBJECTIVE: After pain and stiffness, one of the most important complaints of patients with ankylosing spondylitis (AS) is disability. The main aims of treatment are to control pain but also to improve function. Various methods of assessing function exist but are either not specific for the disease or have not been adequately validated. As a result of this deficiency we developed the Bath Ankylosing Spondylitis Functional Index (BASFI) as a new approach to defining and monitoring functional ability in patients with AS.
METHODS: This self-assessment instrument was designed by a team of medical professionals in conjunction with patients, and consists of 8 specific questions regarding function in AS and 2 questions reflecting the patient's ability to cope with everyday life. Each question is answered on a 10 cm horizontal visual analog scale, the mean of which gives the BASFI score (0-10). The questionnaire was completed 257 times in total: once by 116 outpatients and by 47 inpatients on 3 occasions over a 3-week intensive physiotherapy course. In addition, the instrument was compared with the Dougados functional index.
RESULTS: Patients scores covered 95% of the BASFI range, giving a normal distribution of results. In contrast only 65% of the Dougados functional index scale was used. Furthermore, over the 3 week period of inpatient treatment, the BASFI revealed a significant improvement in function (20%, p = 0.004) while there was a less impressive change in the Dougados functional index (6%, p = 0.03). This demonstrates the superior sensitivity of the BASFI: Consistency was good for both indices (p < 0.001), as was the relationship between patient perception of function and function as assessed by an external observer (p < 0.001).
CONCLUSION: The BASFI satisfies the criteria required of a functional index: it is quick and easy to complete, is reliable and is sensitive to change across the whole spectrum of disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7699629

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  643 in total

1.  Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up.

Authors:  E Kruithof; F Van den Bosch; D Baeten; A Herssens; F De Keyser; H Mielants; E M Veys
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

2.  Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.

Authors:  Erkan Kilic; Gamze Kilic; Ozgur Akgul; Salih Ozgocmen
Journal:  Rheumatol Int       Date:  2014-11-04       Impact factor: 2.631

3.  Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study.

Authors:  F Van den Bosch; E Kruithof; D Baeten; F De Keyser; H Mielants; E M Veys
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

4.  The gait deviations of ankylosing spondylitis with hip involvement.

Authors:  Guoning Zhang; Jia Li; Zhengliang Xia; Weidong Xu
Journal:  Clin Rheumatol       Date:  2019-01-04       Impact factor: 2.980

5.  Relationship between spinal mobility measures and quality of life in patients with ankylosing spondylitis.

Authors:  Vladislava Vesović-Potić; Dusan Mustur; Dejana Stanisavljević; Tatjana Ille; Mihailo Ille
Journal:  Rheumatol Int       Date:  2009-01-27       Impact factor: 2.631

6.  Gender differences in Iranian patients with ankylosing spondylitis.

Authors:  Abtin Shahlaee; Mahdi Mahmoudi; Mohammad Hossein Nicknam; Elham Farhadi; Sasan Fallahi; Ahmad Reza Jamshidi
Journal:  Clin Rheumatol       Date:  2013-11-28       Impact factor: 2.980

7.  Evaluation of the Turkish version of the Dougados functional index in ankylosing spondylitis.

Authors:  Huseyin T E Ozer; Tunay Sarpel; Bozkurt Gulek; Z Nazan Alparslan; Eren Erken
Journal:  Rheumatol Int       Date:  2005-03-02       Impact factor: 2.631

8.  Physical activity in patients with axial spondyloarthritis: a cross-sectional study of 203 patients.

Authors:  Stéphanie Fabre; Anna Molto; Sabrina Dadoun; Christopher Rein; Christophe Hudry; Sarah Kreis; Bruno Fautrel; Edouard Pertuiset; Laure Gossec
Journal:  Rheumatol Int       Date:  2016-09-24       Impact factor: 2.631

9.  Performance of different criteria sets for inflammatory back pain in patients with axial spondyloarthritis with and without radiographic sacroiliitis.

Authors:  Dilek Solmaz; Servet Akar; Ozgul Soysal; Yeşim Akkoc; Gercek Can; Vedat Gerdan; Merih Birlik; Fatos Onen; Nurullah Akkoc
Journal:  Clin Rheumatol       Date:  2014-04-27       Impact factor: 2.980

10.  Association of cigarette smoking with Chinese ankylosing spondylitis patients in Taiwan: a poor disease outcome in systemic inflammation, functional ability, and physical mobility.

Authors:  Chun-Hsiung Chen; Hung-An Chen; Chin-Li Lu; Hsien-Tzung Liao; Chin-Hsiu Liu; Chang-Youh Tsai; Chung-Tei Chou
Journal:  Clin Rheumatol       Date:  2013-01-18       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.